Adjuvant action of murine IL-2/Ig plasmid after intramuscular immunization with Indian HIV-1 subtype C recombinant env.gp 120 construct

Viral Immunology

Volumn 18, Issue 4, 2005, Pages 649-656

  Aggarwal, Priya ^a   Kumar, Sanjeev ^a   Vajpayee, Madhu ^a   Seth, Pradeep ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; ENVELOPE PROTEIN; GAMMA INTERFERON; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN; INTERLEUKIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRAIN COS7; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG POTENTIATION; EPIDEMIC; FEMALE; GENE CONSTRUCT; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNITY; IMMUNIZATION; MOLECULAR CLONING; MOUSE; NONHUMAN; PLASMID; RECOMBINANT GENE;

ADJUVANTS, IMMUNOLOGIC; AIDS VACCINES; ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; IMMUNITY, CELLULAR; INJECTIONS, INTRAMUSCULAR; INTERFERON TYPE II; INTERLEUKIN-2; MICE; MICE, INBRED BALB C; VACCINES, DNA;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE;

EID: 29844445177     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2005.18.649     Document Type: Article

References (36)

1. Arai, K.I., F. Lee, A. Miyajima, S. Miyatake, N. Arai, and T. Yokota. 1990. Cytokines: coordinators of immune and inflammatory responses. Annu. Rev. Biochem. 59:783-836.
2. Arno, A., L. Ruiz, M. Juan, et al. 1999. Efficacy of low-dose subcutaneous interleukin-2 to treat advanced human immunodeficiency virus type 1 in persons with ≤ 250/microL CD4 T cells and undetectable plasma virus load. J. Infect. Dis. 180:56-60.
3. Arora, A., J.L. Fahey, and P. Seth. 2001. DNA vaccine for the induction of immune responses against HIV-1 subtype C envelope gene in mice. Gene Ther. Mol. Biol. 6:79-89.
4. Barouch, D.H., S. Santra, J.E. Schmitz, et al. 2000. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science 290:486-492.
5. Barouch, D.H., S. Santra, T.D. Steenbeke, et al. 1998. Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration. J. Immunol. 161:1875-1882.
6. Bu J., Y. Song, G. Rompato, D.J. Burgess, and A.E. Garmendia. 2003. Co-delivery of IL-2 or liposomes augment the responses of mice to a DNA vaccine for pseudorabies virus IE180. Comp. Immunol. Microbiol. Infect. Dis. 3:175-187.
7. Chen, Y., E.J. Usherwood, S.L. Surman, T.L. Hogg, and D.L. Woodland. 1999. Long-term CD8+ T cell memory to Sendai virus elicited by DNA vaccination. J. Gen. Virol. 80:1393-1399.
8. Chow, Y.H., W.L. Huang, W.K. Chi, Y.D. Chu, and M.H. Tao. 1997. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J. Virol. 71:169-178.
9. Chun, T.W., D. Engel, S.B. Mizell, et al. 1999. Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy. Nat. Med. 5:651-655.
10. Collins, R.A., and G. Oldham. 1993. Recombinant human interleukin 2 induces proliferation and immunoglobulin secretion by bovine B-cells: tissue differences and preferential enhancement of immunoglobulin A, Vet. Immunol. Immunopathol. 36:31-34.
11. Davey, R.T. Jr., R.L. Murphy, F.M. Graziano, et al. 2000. Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: a randomized controlled trial. J. Am. Med. Assoc. 284:183-189.
12. Du, D.W., Z.S. Jia, G.Y. Li, and Y.Y. Zhou. 2003. HBV DNA vaccine with adjuvant cytokines induced specific immune responses against HBV infection. World J. Gastroenterol. 9:108-111.
13. Geissler, M., A. Gesien, K. Tokushige, and J.J. Wands. 1997. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J. Immunol. 158:1231-1237.
14. Hassett, D.E., J. Zhang, M. Slifka, and J.L. Whitton. 2000. Immune responses following neonatal DNA vaccination are long-lived, abundant, and qualitatively similar to those induced by conventional immunization. J. Virol. 74:2620-2627.
15. Janeway, C.A., Jr., and K. Bottomly. 1994. Signals and signs for lymphocyte responses. Cell 76:275-285.
16. Kim, J.J., M.L. Bagarazzi, N. Trivedi, et al. 1997. Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes. Nat. Biotechnol. 15:641-646.
17. Kim, J.J., J.S. Yang, T.C. VanCott, et al. 2000. Modulation of antigen-specific humoral responses in rhesus macaques by using cytokine cDNAs as DNA vaccine adjuvants. J. Virol. 74:3427-3429.
18. Kovacs. J.A., M. Baseler, R.J. Dewar, et al. 1995. Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study. N. Engl. J. Med. 332:567-575.
19. Kuroda, K., J. Yagi, K. Imanishi, et al. 1996. Implantation of IL-2-containing osmotic pump prolongs the survival of superantigen-reactive T cells expanded in mice injected with bacterial superantigen. J. Immunol. 157:1422-1431.
20. Lofthouse, S.A., A.E. Andrews, M.J. Elhay, V.M. Bowles, E.N.T. Meeusen, and A.D. Nash. 1996. Cytokines as adjuvants for ruminant vaccines. Int. J. Parasitol. 26:845-855.
21. Nakanishi, K., T. Yoshimoto, H. Tsutsui, and H. Okamura. 2001. Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. 19:423-474.
22. Nohria, A., and R.H. Rubin. 1994. Cytokines as potential vaccine adjuvants. Biotherapy 7:261-269.
23. Nunberg, J.H., M.V. Doyle, S.M. York, and C.J. York. 1989. Interleukin-2 acts as an adjuvant to increase the potency of inactivated rabies virus vaccine. Proc. Natl. Acad. Sci. U.S.A. 86:4240-4243.
24. Paola, R., F. Maria, C. Lmerio, and B. Filippo. 2002. Cytokines as natural adjuvants for vaccines: where are we now? Trends Immunol. 23:381-383.
25. Parker, S.E., F. Borellini, M.L. Wenk, et al. 1999. Plasmid DNA malaria vaccine: tissue distribution and safety studies in mice and rabbits. Hum. Gene. Ther. 10:741-758.
26. Raz, E., A. Watanabe, S.M. Baird, et al. 1993. Systemic immunological effects of cytokine genes injected into skeletal muscle. Proc. Natl. Acad. Sci. U.S.A. 190:4523-4527.
27. Reddy, P.G., F. Blecha, H.C. Minocha, et al. 1989. Bovine recombinant interleukin-2 augments immunity and resistance to bovine herpesivirus infection. Vet. Immunol. Immunopathol. 23:61-74.
28. Rook, G.A. 1993. New meaning for an old word: adjuvanticity, cytokines and T cells. Immunol. Today 14:95-96.
29. Rosenberg, P.S., R.J. Biggar, J.J. Goedert. 1994. Declining age at HIV infection in the United States. N. Engl. J. Med. 11:789-790.
30. Shimizu, K., R.C. Fields, M. Giedlin, J.J. Mule. 1999. Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines. Proc. Natl. Acad. Sci. U.S.A. 96:2268-2273.
31. Siegel, J.P., M. Sharon, P.L. Smith, and W.J. Leonard. 1987. The IL-2 receptor β chain (p70): role in mediating signals for LAK, NK, and proliferative activities. Science 238:75-78.
32. Smith, K.A. 1988. Interleukin-2: inception, impact, and implications. Science 240:1169-1176.
33. Weinberg, A., and A. Merigan. 1988. Recombinant interleukin-2 as an adjuvant for vaccine-induced protection. Immunization of guinea pigs with herpes simplex virus subunit vaccines. J. Immunol. 140:294-299.
34. Xin, K.Q., K. Hamajima, S. Sasaki, et al. 1998. Intranasal administration of human immunodeficiency virus type-1 (HIV-1) DNA vaccine with interleukin-2 expression plasmid enhances cell-mediated immunity against HIV-1. Immunology 94:438-444.
35. Xin, K.Q., K. Hamajima, S. Sasaki, T. Tsuji, S. Watabe, E. Okada, K. Okuda. 1999. IL-15 expression plasmid enhances cell-mediated immunity induced by an HIV-1 DNA vaccine. Vaccine 17:858-866.
36. Zheng, X.X., A.W. Steele, P.W. Nickerson, W. Steurer, J. Steiger, T.B. Strom. 1995. Administration of noncytolytic IL-10/Fc in murine models of lipopolysaccharide-induced septic shock and allogeneic islet transplantation. J. Immunol. 154:5590-5600.